# A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne

> **NCT01844752** · PHASE2 · COMPLETED · sponsor: **Novan, Inc.** · enrollment: 153 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** NVN1000 1% Gel
- **DRUG:** NVN1000 4% Gel
- **DRUG:** Vehicle Gel

## Key facts

- **NCT ID:** NCT01844752
- **Lead sponsor:** Novan, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2018-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01844752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01844752, "A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01844752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*